Testing effectiveness (Phase 2)Study completedNCT00345345
What this trial is testing
Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte Leukemia
Who this might be right for
T-LGL Lymphoproliferative Disorders
National Heart, Lung, and Blood Institute (NHLBI) 29